APOB gene polymorphisms may affect the risk of minor or minimal bleeding complications in patients on warfarin maintaining therapeutic INR
- 11 June 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 27 (10) , 1542-1549
Abstract
The purpose of this study was to investigate influence of gene polymorphisms of APOB and APOE on risk of bleeding complications at therapeutic INR, during warfarin treatment in Korean patients with mechanical cardiac valves. The study included 142 patients from the EwhA-Severance Treatment Group (EAST) of Warfarin. A total of 12 SNPs was investigated. Five SNPs of APOB (c.13013G>A, c.1853C>T, c.1594C>T, c.293C>T, and c.7545C>T) and five SNPs of APOE (g.4798T>G, g.6406G>A, g.10413T>C, c.388T>C, and c.526C>T) were selected. In addition to selected SNPs, VKORC1 g.6399C>T, and CYP2C9 c.1075A>C, which were known to have significant effects on warfarin stable doses, were also included in the study. Two SNPs of APOB (c.293C>T and c.1853C>T) were associated with bleeding complications. T allele carriers of c.293C>T had 8.6 times (95% CI 2.9–25.5, p < 0.001) increased risk of bleeding, and attributable risk was 88.3%. C allele carriers of c.1853C>T had 6.4 times (95% CI 2.3–17.9, p < 0.001) increased risk of bleeding after adjusting for covariates (attributable risk of 84.3%). AUROC values of models that included c.1853C>T and c.293C>T were 0.771 and 0.802, respectively. Among demographic characteristics, age was the only significant factor. This study revealed that APOB was associated with bleeding complications in patients with warfarin treatment after mechanical cardiac valves.Keywords
Funding Information
- National Research Foundation of Korea (2017R1D1A1B03034033)
This publication has 34 references indexed in Scilit:
- Risk Factors and Their Combined Effects on the Incidence Rate of Subarachnoid Hemorrhage – A Population-Based Cohort StudyPLOS ONE, 2013
- Assessing bleeding risk in patients taking anticoagulantsJournal of Thrombosis and Thrombolysis, 2013
- Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control studyAnnals of Indian Academy of Neurology, 2012
- Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapyJournal of Thrombosis and Haemostasis, 2010
- Low Level of Low-Density Lipoprotein Cholesterol Increases Hemorrhagic Transformation in Large Artery Atherothrombosis but Not in CardioembolismStroke, 2009
- Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation StudyJournal of the American Geriatrics Society, 2006
- Binding of Low Density Lipoprotein to Platelet Apolipoprotein E Receptor 2′ Results in Phosphorylation of p38MAPKJournal of Biological Chemistry, 2004
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Apolipoprotein E polymorphism in health and diseaseAmerican Heart Journal, 1987
- Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community.Stroke, 1982